EFFECT: A randomized phase II study to evaluate the EFficacy and impact on Function of two different doses of nab-paclitaxEl in elderly patients with advanCed breasT cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms EFFECT
- 31 Jul 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Sep 2017.
- 02 Feb 2017 Planned End Date changed from 1 Apr 2017 to 1 Dec 2017.
- 02 Feb 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Apr 2017.